Bydgoszcz, POLAND - 11 Aug `17Simvastatin And Atorvastatin Effect On Vitiligo

Official Title: The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo (EVRAAS)

In Brief: The aim of this study is to evaluate the influence of simvastatin and atorvastatin on vitiligous lesions in patients with non-segmental vitiligo.

Ages Eligible: 18 Years to 80 Years

Start Date: August 11, 2017

Completion Date (estimated): April 2018

Status: Unknown, not recruiting

Study ID from ClinicalTrials.gov: NCT03247400
Other Study ID Numbers: NCU 631

Location: Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University, Faculty of Medicine, Bydgoszcz, Cuiavian-Pomeranian, Poland, 85094

Contact: To learn more about this study, you or your doctor may contact Anna Niezgoda, MD by phone +48 606889288 or email anna.niezg@gmail.com. Please refer to this study by its NCT number.

FAQOther Questions

  • How can I explain vitiligo to my children?

    Vitiligo can be puzzling for a child because a person who has it isn't "ill" in a common sense.  To choose the right words to explain vitiligo diagnosis to a child, first consi...

  • Is vitiligo contagious?

    Vitiligo is NOT contagious. It cannot be passed on or caught from touching someone with vitiligo, shaking hands, swimming in the same pool, sharing towels, sitting next to someo...

  • How to get insurance coverage for vitiligo treatments?

    Most of health insurance companies will initially reject claims for vitiligo doctor visits or phototherapy treatments but with enough efforts you can have a substantial part of ...